Nishant Tageja
- Hematology top 5%
- Multiple Myeloma Research and Treatments 14
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 3
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
-
- Cancer Treatment and Pharmacology 3
-
- Lymphoma Diagnosis and Treatment 4
-
- Protein Degradation and Inhibitors 3
-
- Nausea and vomiting management 3
- Anesthesia and Pain Management 3
- Co-authors
- Ola LandgrenHunter GroningerJeffrey A. ZonderNeha KordeElisabet E. ManasanchManisha BhutaniMark RoschewskiMary Kwok
- Cited by
- HematologyGeneticsOncology
- Journals
- Journal of Clinical Oncology (1 paper)Blood (3 papers)The Journal of Clinical Endocrinology & Metabolism (1 paper)
- Partner nations
- United StatesIndiaCanada
In The Last Decade
Nishant Tageja
33 papers receiving 504 citations
Peers
Comparison fields: 5 of 71
- Hematology 212
- Genetics 115
- Oncology 163
- Pathology and Forensic Medicine 76
- Molecular Biology 188
Countries citing papers authored by Nishant Tageja
This map shows the geographic impact of Nishant Tageja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nishant Tageja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nishant Tageja more than expected).
Fields of papers citing papers by Nishant Tageja
This network shows the impact of papers produced by Nishant Tageja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nishant Tageja. The network helps show where Nishant Tageja may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nishant Tageja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 5 | |
| 2 | 2018 | 12 | |
| 3 | 2018 | 1 | |
| 4 | 2014 | 15 | |
| 5 | 2014 | 12 | |
| 6 | 2014 | 17 | |
| 7 | 2014 | 14 | |
| 8 | 2013 | 28 | |
| 9 | 2013 | 63 | |
| 10 | 2013 | 4 | |
| 11 | 2012 | 17 | |
| 12 | 2011 | 28 | |
| 13 | 2011 | 6 | |
| 14 | 2010 | 14 | |
| 15 | 2010 | 4 | |
| 16 | 2010 | 1 | |
| 17 | 2010 | 21 | |
| 18 | 2009 | 12 | |
| 19 | 2009 | 29 | |
| 20 | 2009 | 17 |
About Nishant Tageja
Nishant Tageja is a scholar working on Hematology, Genetics and Oncology, having authored 33 papers that have together received 516 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Lymphoma Diagnosis and Treatment (4 papers), Nausea and vomiting management (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Anesthesia and Pain Management (3 papers), Cancer Treatment and Pharmacology (3 papers), Protein Degradation and Inhibitors (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (212 citations), Genetics (115 citations) and Oncology (163 citations). Nishant Tageja has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Ola Landgren, Hunter Groninger, Jeffrey A. Zonder, Neha Korde, Elisabet E. Manasanch, Manisha Bhutani, Mark Roschewski, Mary Kwok, Jason Valent and Adriana Zingone. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.